title: Effects of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on haematopoietic regeneration and resistance to infection of sublethally irradiated mice.
abstract: The influence of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) treatment on the reversal of irradiation-induced leukopenia (granulocytopenia, monocytopenia) and thrombocytopenia and its ability to protect mice against lethal infections were investigated in this study. The administration of pGPL-Mc to irradiated mice significantly accelerated the recovery of leukocyte and thrombocyte numbers in the peripheral blood. Granulocytes and monocytes were the principal cells of the leukocyte population that responded to the potent stimulus of this product. The reversal of granulocytopenia and monocytopenia in treated mice was achieved on day 14 and reached a peak value on day 20. Responses in mice receiving 100 mg/kg of pGPL-Mc was about 40-fold compared to controls and about 4-fold compared to the rhG-CSF-treated group. Normal levels of thrombocytes were reached by day 17 in mice treated with 100 mg/kg and by day 20 in those receiving 25 mg/kg of pGPL-Mc. The administration of pGPL-Mc to mice with irradiation-induced granulocytopenia was characterized by highly significant protection of these animals against lethal Klebsiella pneumoniae or Escherichia coli infections. Therefore, pGPL-Mc appears to possess a considerable potential for improvement of the outcome of radiotherapy and may contribute to the successful avoidance of irradiation-induced toxicities.
authors: Institut d'Immunologie animale et comparée, Ecole Nationale Vétérinaire d'Alfort, Maisons Alfort, France.
authors: T
authors: T
authors: Neway
authors: P
authors: P
authors: Mazetier-Chicha
authors: P
authors: P
authors: Devauchelle
authors: D
authors: D
authors: Thibault
authors: H J
authors: HJ
authors: Boulouis
authors: F
authors: F
authors: Barrat
authors: S
authors: S
authors: Vincent-Naulleau
authors: C
authors: C
authors: Pilet
mesh_terms: D000380:Agranulocytosis / Q000188:drug therapy*; D000818:Animals; D001425:Bacterial Outer Membrane Proteins / Q000627:therapeutic use*; D004198:Disease Susceptibility; D004927:Escherichia coli Infections / Q000517:prevention & control; D005260:Female; D007710:Klebsiella Infections / Q000517:prevention & control; D007958:Leukocyte Count; D051379:Mice; D008807:Mice, Inbred BALB C; D009000:Monocytes / Q000187:drug effects* / Q000528:radiation effects*; D016926:Mycobacterium chelonae / Q000737:chemistry*; D011830:Radiation Effects; D013921:Thrombocytopenia / Q000188:drug therapy*
chemical_list: D001425:Bacterial Outer Membrane Proteins